The Incidence of Imaging Abnormalities after Stereotactic Radiosurgery for Cerebral Arteriovenous and Cavernous Malformations

Author(s):  
Sławomir Blamek ◽  
Marek Boba ◽  
Dawid Larysz ◽  
Adam Rudnik ◽  
Kornelia Ficek ◽  
...  
Neurosurgery ◽  
1999 ◽  
Vol 44 (2) ◽  
pp. 424-424 ◽  
Author(s):  
Randall W. Porter ◽  
Paul W. Detwiler ◽  
Patrick P. Han ◽  
Robert F. Spetzler

Neurosurgery ◽  
2002 ◽  
Vol 50 (6) ◽  
pp. 1190-1198 ◽  
Author(s):  
Toshinori Hasegawa ◽  
James McInerney ◽  
Douglas Kondziolka ◽  
John Y.K. Lee ◽  
John C. Flickinger ◽  
...  

Abstract OBJECTIVE Stereotactic radiosurgery has been used for patients with high-risk cavernous malformations of the brain. We performed radiosurgery for patients with symptomatic, imaging-confirmed hemorrhages for which resection was believed to be associated with high risk. This study examines the long-term hemorrhage rate after radiosurgery. METHODS We reviewed data obtained before and after gamma knife radiosurgery on 82 patients treated between 1987 and 2000. Most patients had multiple hemorrhages from brainstem or diencephalic cavernous malformations. Follow-up data were examined to identify hemorrhages, and an overall hemorrhage rate was calculated. RESULTS Observation before treatment averaged 4.33 years (range, 0.17–18 yr) for a total of 354 patient-years. During this period, 202 hemorrhages were observed, for an annual hemorrhage rate of 33.9%, excluding the first hemorrhage. Temporal clustering of hemorrhages was not significant. After radiosurgery, patient follow-up averaged 5 years (range, 0.42–12.08 yr), for a total of 401 patient-years. During this period, 19 hemorrhages were identified, 17 in the first 2 years posttreatment and 2 after 2 years. The annual hemorrhage rate was 12.3% per year for the first 2 years after radiosurgery, followed by 0.76% per year from Years 2 to 12. Eleven patients had new neurological symptoms without hemorrhage after radiosurgery (13.4%). The symptoms were minor in six of these patients and temporary in five. CONCLUSION Radiosurgery confers a reduction in the risk of hemorrhage for high-risk cavernous malformations. Risk reduction, although in evidence during initial follow-up, is most pronounced after 2 years. Given the difficulty of identifying high-risk patients, treatment after one major hemorrhage should be considered in selected younger patients. Such a strategy warrants further investigation.


2014 ◽  
Vol 120 (4) ◽  
pp. 982-987 ◽  
Author(s):  
Xin-Yu Lu ◽  
Hui Sun ◽  
Jian-Guo Xu ◽  
Qiao-Yu Li

Object Over the last two decades, stereotactic radiosurgery (SRS) has arisen as a promising approach in the management of brainstem cavernous malformations (CMs). In the present study, the authors report a systematic review and meta-analysis of the available published data regarding the radiosurgical management of brainstem CMs. Methods To identify eligible studies, systematic searches for brainstem CMs treated with SRS were conducted in major scientific publication databases. The search yielded 5 studies, which were included in the meta-analysis. Data from 178 patients with brainstem CMs were extracted. Hemorrhage rates before and after SRS were calculated, a meta-analysis was performed, and the risk ratio (RR) was determined. Results Four studies showed a statically significant reduction in the annual hemorrhage rate after SRS. The overall RR was 0.161 (95% CI 0.052–0.493; p = 0.001), and 21 patients (11.8%) had transient or permanent neurological deficits. Conclusions The present meta-analysis for the radiosurgical management of brainstem CMs shows that SRS can decrease the rate of repeat hemorrhage and has a low rate of adverse effects compared with surgery. The authors suggest that SRS may be considered as an alternative treatment for brainstem CMs that are inoperable or have a high operative risk.


Neurology ◽  
2019 ◽  
Vol 93 (21) ◽  
pp. e1971-e1979 ◽  
Author(s):  
Michiel H.F. Poorthuis ◽  
Leon A. Rinkel ◽  
Simon Lammy ◽  
Rustam Al-Shahi Salman

ObjectiveThe efficacy of stereotactic radiosurgery (SRS) for the treatment of cerebral cavernous malformations (CCMs) is uncertain, so we set out to quantify clinical outcomes after SRS for CCM and compare them to microsurgical excision or conservative management.MethodsWe searched Ovid Medline and Ovid EMBASE from inception until June 1, 2018, for peer-reviewed publications describing clinical outcomes after SRS for ≥10 people with CCM in cohorts with or without a comparison group treated with neurosurgical excision or conservative management. Two reviewers independently extracted data from the included studies to quantify cohort characteristics and the incidence of the primary outcome (death attributable to CCM or its treatment) and secondary outcomes (incident nonfatal symptomatic intracerebral hemorrhage [ICH] and incident nonhemorrhagic persistent focal neurologic deficit [FND]). We assessed whether comparative studies showed a dramatic association (meaning the conventionally calculated probability comparing 2 differently managed patient groups from the same population was <0.01 with a rate ratio greater than 10).ResultsWe included 30 cohort studies involving a total of 1,576 patients undergoing SRS for CCM. Four nonrandomized studies compared SRS to other treatment strategies, but did not demonstrate dramatic associations. During a median follow-up of 48 (interquartile range 35–62) months after SRS, the annual incidences (95% confidence interval) of outcomes were death 0.18% (0.10–0.31), ICH 2.40% (2.05–2.80), FND 0.71% (0.53–0.96), and the composite of death, ICH, or FND 3.63% (3.17–4.16). Outcomes did not differ by CCM location or type of SRS.ConclusionAfter SRS for CCM, the annual incidences of death, ICH, and FND are <5% and seem comparable to outcomes without SRS. A randomized trial of SRS for CCM is needed.


Neurosurgery ◽  
2001 ◽  
Vol 49 (2) ◽  
pp. 509
Author(s):  
Toshinori Hasegawa MD ◽  
James McInerney MD ◽  
John Y.K. Lee ◽  
Douglas Kondziolka MD ◽  
John Flickinger MD ◽  
...  

2019 ◽  
Vol 124 ◽  
pp. e58-e64 ◽  
Author(s):  
Rachel Jacobs ◽  
Hideyuki Kano ◽  
Bradley A. Gross ◽  
Ajay Niranjan ◽  
Edward A. Monaco ◽  
...  

2013 ◽  
Vol 24 (4) ◽  
pp. 575-589 ◽  
Author(s):  
Gábor Nagy ◽  
Andras A. Kemeny

Sign in / Sign up

Export Citation Format

Share Document